Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Emmerich

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolismE Arnaud, V Nicaud, O Poirier, et al.
Journal De Medecine Vasculaire|December 4, 2021
Late limb ischemia diagnosis in a childE Giauffret, V Milongo, S Sebbane, et al.
European Heart Journal|February 1, 1990
Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemiaJ Emmerich, I Aubert, B Bauduceau, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Thrombomodulin promoter mutations, venous thrombosis, and varicose veinsL Le Flem, L Mennen, M L Aubry, et al.
Thrombosis and Haemostasis|July 15, 2000
Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic diseaseO Lozinguez, E Arnaud, L Belec, et al.
Journal of Thrombosis and Haemostasis : JTH|March 20, 2014
No effect of isolated long-term supine immobilization or profound prolonged hypoxia on blood coagulationA Venemans-Jellema, A J M Schreijer, S Le Cessie, et al.
Presse Medicale (Paris, France : 1983)|May 14, 1988
[Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia]I Aubert, J Emmerich, Y Charpak, et al.
Diabetes & Metabolism|March 13, 1998
[Arteriopathy of the lower limb in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the study of Diabetes and Metabolic Diseases)]A C Benhamou, M Dadon, J Emmerich, et al.
Thrombosis and Haemostasis|June 1, 1997
The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du MyocardeS M Herrmann, O Poirier, P Marques-Vidal, et al.
Journal De Medecine Vasculaire|May 15, 2021
Foot ischemia related to essential thrombocytemia and atherosclerosisF Legrand, A Fernex de Mongex, M Delrue, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolismE Arnaud, V Nicaud, O Poirier, et al.
Journal De Medecine Vasculaire|December 4, 2021
Late limb ischemia diagnosis in a childE Giauffret, V Milongo, S Sebbane, et al.
European Heart Journal|February 1, 1990
Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemiaJ Emmerich, I Aubert, B Bauduceau, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Thrombomodulin promoter mutations, venous thrombosis, and varicose veinsL Le Flem, L Mennen, M L Aubry, et al.
Thrombosis and Haemostasis|July 15, 2000
Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic diseaseO Lozinguez, E Arnaud, L Belec, et al.
Journal of Thrombosis and Haemostasis : JTH|March 20, 2014
No effect of isolated long-term supine immobilization or profound prolonged hypoxia on blood coagulationA Venemans-Jellema, A J M Schreijer, S Le Cessie, et al.
Presse Medicale (Paris, France : 1983)|May 14, 1988
[Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia]I Aubert, J Emmerich, Y Charpak, et al.
Diabetes & Metabolism|March 13, 1998
[Arteriopathy of the lower limb in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the study of Diabetes and Metabolic Diseases)]A C Benhamou, M Dadon, J Emmerich, et al.
Thrombosis and Haemostasis|June 1, 1997
The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du MyocardeS M Herrmann, O Poirier, P Marques-Vidal, et al.
Journal De Medecine Vasculaire|May 15, 2021
Foot ischemia related to essential thrombocytemia and atherosclerosisF Legrand, A Fernex de Mongex, M Delrue, et al.
Pageof 21